Navigation Links
Express Scripts Announces Plan to Build Fourth Building at Headquarters Campus
Date:12/17/2010

its two headquarters buildings on the campus of the University of Missouri–St. Louis.

The initiative, projected to cost in excess of $70 million, will bring together functions now performed at several sites in the Riverport area of Maryland Heights. Approximately 1,500 Express Scripts employees will move into the new facility upon completion, and the company will create 150 jobs in the area within two years of opening the building.

George Paz, chairman, president and chief executive officer of Express Scripts, said: "By increasing our operational efficiencies, development of this new site advances Express Scripts' mission of making the use of prescription drugs safer and more affordable. It also continues our commitment to attracting a high-quality, diverse workforce from the St. Louis metropolitan area."

Groundwork has started for the project. Pending necessary approvals and permits, the scheduled completion is the fourth quarter of 2011.

"Express Scripts appreciates the efforts of Governor Jay Nixon and County Executive Charlie Dooley and their staffs, as well as our development partners, in helping to help make this happen," Paz said. "We are increasingly happy to call the St. Louis region our home and proud of the economic benefits our growth has contributed to the state and the county."

The economic impact study is available at www.express-scripts.com/pressroom/pressreleases/UMSLEconomicImpactStudy.pdf.

About Express ScriptsExpress Scripts, Inc., one of the largest pharmacy benefit management companies in North America, is leading the way toward creating better health and value for patients through Consumerology®, the advanced application of the behavioral sciences to healthcare. This approach is helping millions of members realize greater healthcare outcomes and lowering cost by assisting in influencing their
'/>"/>

SOURCE Express Scripts, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Express Scripts Establishes Industrys Most Comprehensive Specialty Benefits Organization; Enhances Patient Care and Guarantees Cost Savings
2. Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance
3. Express Scripts to Present at Investor Conferences in November
4. Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
5. NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, The Directors Common Fund to Provide Human Tissue for GTEx, the New Genotype-Tissue Expression Project
6. Express Scripts Announces Third Quarter 2010 Earnings and 2011 Earnings Guidance Conference Call
7. Express Scripts Accurately Predicts Which Patients Are Likely to Ignore Doctors Orders
8. Express Scripts Completes Spinoff of Rx Outreach
9. Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthr
10. Express Scripts to Present at Barclays 2010 Global Healthcare Conference
11. Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 2015 EUSA Pharma (EUSA), a ... announced the appointment of Lee Morley as ... Non-Executive Director.  Bryan Morton, who established EUSA Pharma as ... Lee Morley joins from Jazz ... of Commercial for Europe and ...
(Date:4/20/2015)... KUALA LUMPUR, Malaysia , April 20, 2015 /PRNewswire/ ... 2015, resulting in a scarcity of opportunities for generic ... drug manufacturers in the region are looking beyond the ... the quality of existing drugs. Certain established generic manufacturers ... research and development of new molecules, although the impact ...
(Date:4/20/2015)... , April 20, 2015 This report analyzes the ... following Product Segments: Non-Powered Breast Pumps, and Powered Breast Pumps. ... Canada , Japan , ... Rest of World. Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
Breaking Medicine Technology:EUSA Pharma Appoints Lee Morley as Chief Executive and Industry Veteran Göran Ando to Board of Directors 2EUSA Pharma Appoints Lee Morley as Chief Executive and Industry Veteran Göran Ando to Board of Directors 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 2Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 3Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 4Generic Drug Companies in Asia Focus More on Market Expansion and Quality, Less on Patent Cliff, Finds Frost & Sullivan 5World Breast Pumps Industry 2World Breast Pumps Industry 3World Breast Pumps Industry 4World Breast Pumps Industry 5World Breast Pumps Industry 6World Breast Pumps Industry 7World Breast Pumps Industry 8World Breast Pumps Industry 9World Breast Pumps Industry 10World Breast Pumps Industry 11World Breast Pumps Industry 12World Breast Pumps Industry 13World Breast Pumps Industry 14
... NEW YORK, Oct. 6 Reportlinker.com announces ... available in its catalogue. , ... Pharma and Biotech , ... The Drug Delivery Partnering Agreements in Pharma ...
... N.J., Oct. 6 Centocor Ortho Biotech Inc. and ... the European Commission has approved SIMPONI(TM) (golimumab) as a ... rheumatoid arthritis (RA), active and progressive psoriatic arthritis (PsA) ... In the European Union, SIMPONI is approved as a ...
Cached Medicine Technology:Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 2Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 3Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 4Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 5Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 6Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech 7SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 2SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 3SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 4SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 5SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 6SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 7SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 8SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 9SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector 10
(Date:4/21/2015)... Washington, DC (PRWEB) April 21, 2015 ... operations and Information Technology advisory firm that helps ... technological change, today announced that the Association ... Optimity a Preferred Vendor. ACAP represents 58 local, ... serve more than 13 million people primarily enrolled ...
(Date:4/21/2015)... FL (PRWEB) April 21, 2015 AxoGen, ... on the peripheral nerve repair market, will report results ... 5, 2015 following the close of the market. ... webcast for the investment community following the release at ... phone are invited to call toll free at 1.877.407.0993 ...
(Date:4/21/2015)... April 21, 2015 The PracticeMatch Career ... 5:00 to 8:00 pm at the William and Ida Friday ... NC 27599. More than 50 hospitals, clinics and groups with ... specialties will be represented. Attendees will enjoy free hors d’oeuvres ... Fairs for PracticeMatch says “Chapel Hill is an ...
(Date:4/21/2015)... With a growing number of Americans retiring abroad, ... international political instability and terrorism top the list of ... a global insurance provider with 68 years’ experience covering ... citizenship, also found strong concern but lack of information ... overseas . , Asked to choose the risks of ...
(Date:4/21/2015)... Pharmacy point of sale software ... Independent Pharmacy Cooperative trade show, to be held April ... , Retail Management Solutions recently became an approved vendor ... Gross, VP of Sales and Marketing. Gross says that ... trade shows in the country -- and this new ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors Named Preferred Vendor by the Association of Community Affiliated Plans (ACAP) 2Health News:AxoGen, Inc. to Report First Quarter Financial Results on May 5, 2015 2Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 2Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 3Health News:Potential Expatriate Retirees Fear Political Violence, International Health Insurance Coverage 2Health News:Potential Expatriate Retirees Fear Political Violence, International Health Insurance Coverage 3Health News:Retail Management Solutions to Attend Upcoming Independent Pharmacy Cooperative Trade Show 2Health News:Retail Management Solutions to Attend Upcoming Independent Pharmacy Cooperative Trade Show 3
... 30 Neogen Corporation,(Nasdaq: NEOG ) announces the following Webcast: , ... When: Tuesday, January 6, 2009 @ 11:00 EST, ... Live over the Internet -- Simply log on to the web at ... above., Contact: Terry Maynard of Neogen Corporation, +1-800-234-5333., , ...
... called "the world,s first disposable hearing aid", and is designed ... needing part-time hearing assistance. , ... ... being called "the world,s first disposable hearing aid", and is ...
... impulsive people, New Year,s resolutions often include being ... on dangerous behavior, such as drug use. But ... as novelty seekers by psychologists--face an uphill battle ... the way their brains process dopamine. The research ...
... YORK and BIRMINGHAM, Ala., Dec. 29 Health,Systems Solutions, Inc. ... ) today announced that they have agreed to extend the ... "We are pleased that, with the ... timetable for the completion of the merger and we are ...
... Dec. 29 Curious about your child,s diet,preventing ... or daughter has a sports-related,injury? , ... youth sports coaches, parents and,athletes focused on education, ... Spine (PEAKOrthopedics.com) to answer these questions,through an online, ...
... have lower risks of Alzheimer,s disease and other cognitive ... In more than half of the studies, published since ... had lower dementia risks than nondrinkers. In only a ... a two-edged sword," said Michael Collins, Ph.D., a professor ...
Cached Medicine News:Health News:Supple, Hi-Flex Cable from Cicoil Makes First Disposable Hearing Aid Possible 2Health News:Risk takers, drug abusers driven by decreased ability to process dopamine 2Health News:Health Systems Solutions and Emageon Extend Merger Closing 2Health News:Health Systems Solutions and Emageon Extend Merger Closing 3Health News:SportZu.tv Partners With PEAK Orthopedics & Spine to Launch an Online Sports Doctor's Office 2Health News:Moderate drinking can reduce risks of Alzheimer's dementia and cognitive decline 2
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: